UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Bone marrow transplantation (Basingstoke), 2021-10, Vol.56 (10), p.2432-2444

2021

Link zum Volltext

Verfügbarkeit prüfen

Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors

Bone marrow transplantation (Basingstoke), 2020-11, Vol.55 (11), p.2147-2159

2020

Link zum Volltext

Verfügbarkeit prüfen

Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects

Viruses, 2024-03, Vol.16 (3), p.459

2024

Link zum Volltext

Verfügbarkeit prüfen

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

Cancer medicine (Malden, MA), 2021-05, Vol.10 (10), p.3214-3223

2021

Link zum Volltext

Verfügbarkeit prüfen

The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.431-440

2020

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.1919-1928

2021

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

Cancers, 2022-05, Vol.14 (11), p.2673

2022

Link zum Volltext

Verfügbarkeit prüfen

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR‐T THERAPY

HemaSphere, 2023-08, Vol.7 (S3), p.e3405129-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Toxicities following CAR-T therapy for hematological malignancies

Cancer treatment reviews, 2022-12, Vol.111, p.102479-102479, Article 102479

2022

Link zum Volltext

Verfügbarkeit prüfen

5525 NEPHROTOXICITY OF CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY: ACUTE KIDNEY INJURY AND ELECTROLYTE DISORDERS

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects

European journal of clinical microbiology & infectious diseases, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting

Journal of medical virology, 2023-09, Vol.95 (9), p.e29107-e29107

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group

American journal of hematology, 2022-01, Vol.97 (1), p.30-42

2022

Link zum Volltext

Verfügbarkeit prüfen

Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease

Bone marrow transplantation (Basingstoke), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?

Clinical microbiology and infection, 2023-08, Vol.29 (8), p.1093-1095

2023

Link zum Volltext

Verfügbarkeit prüfen

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2022-09, Vol.57 (9), p.1389-1398

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors

Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma; Insights into Its Potential Role in the Era of New Immunotherapeutic and Targeted Therapies: The GETH/GELTAMO Experience

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR‐T for Relapsed/Refractory B‐NHL

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR‐T THERAPY

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy

P1151: BENDAMUSTINE‐CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B‐CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T‐CELL THERAPY

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis

Toxicities following CAR-T therapy for hematological malignancies

5525 NEPHROTOXICITY OF CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY: ACUTE KIDNEY INJURY AND ELECTROLYTE DISORDERS

Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects

Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting

SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease

Cytomegalovirus DNAemia in haematological patients undergoing CD19-directed chimeric antigen receptor T-cell therapy: should it be systematically monitored?

Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia

Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy

Suchergebnisse filtern